Philip J. Vickers
CIK: 0001635046
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AKBA
Akebia Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About Vickers Philip J.
Vickers Philip J. (SEC CIK 0001635046) files insider reports with the SEC as Director of Akebia Therapeutics, Inc. (AKBA).
Signal8 holds 2 ownership filings by Vickers Philip J. (1 Form 3, 1 Form 4), filed on Apr 3, 2026. Those filings report 1 transaction, the latest on Apr 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Vickers Philip J.'s filings is in CAMBRIDGE, MA.
Recent filings by Vickers Philip J.
- Apr 1, 2026: Grant or award of AKBA derivative securities (Form 4, code A).
Other insiders filing for Akebia Therapeutics, Inc. (AKBA)
- Butler John P., CEO and President
- Ostrowski Erik, SVP, CFO, CBO & Treasurer
- Wolf Myles, Director
- Smith Cynthia, Director
- ROGERS MICHAEL W, Director
- FRIESON RON, Director